Published on 13 Dec 2023 on Simply Wall St. via Yahoo Finance
Key Insights
Significant control over AC Immune by private equity firms implies that the general public has more power to influence management and governance-related decisionsA total of 4 investors have a majority stake in the company with 55% ownership 14% of AC Immune is held by Institutions
To get a sense of who is truly in control of AC Immune SA (NASDAQ:ACIU), it is important to understand the ownership structure of the business. We can see that private equity firms own the lion's share in the company with 37% ownership. Put another way, the group faces the maximum upside potential (or downside risk).